| Product NDC: | 0469-3016 |
| Proprietary Name: | Prograf |
| Non Proprietary Name: | Tacrolimus |
| Active Ingredient(s): | 5 mg/mL & nbsp; Tacrolimus |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0469-3016 |
| Labeler Name: | Astellas Pharma US, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050709 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19940408 |
| Package NDC: | 0469-3016-01 |
| Package Description: | 10 AMPULE in 1 BOX (0469-3016-01) > 1 mL in 1 AMPULE |
| NDC Code | 0469-3016-01 |
| Proprietary Name | Prograf |
| Package Description | 10 AMPULE in 1 BOX (0469-3016-01) > 1 mL in 1 AMPULE |
| Product NDC | 0469-3016 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tacrolimus |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19940408 |
| Marketing Category Name | NDA |
| Labeler Name | Astellas Pharma US, Inc. |
| Substance Name | TACROLIMUS |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |